Warning: The NCBI web site requires JavaScript to function. more...
Follow-up of endoscopic gastritis after healing with sucralfate or an H2-receptor antagonist.
Guslandi M, Ballarin E, Fanti L, Sorghi M, Tittobello A.
Scand J Gastroenterol Suppl. 1992;191:25-7.
Related citations
Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy. Clinical and endoscopic study.
Sartori S, Nielsen I, Maestri A, Beltrami D, Trevisani L, Pazzi P.
Oncology. 1991;48(5):356-61.
Frequent non-response to histamine H2-receptor antagonists in cirrhotics.
Walker S, Krishna DR, Klotz U, Bode JC.
Gut. 1989 Aug;30(8):1105-9.
Famotidine in the treatment of gastritis.
Miwa T, Miyoshi A.
Scand J Gastroenterol Suppl. 1987;134:46-50.
Effect of acid inhibition on Campylobacter pylori.
Blanco M, Pajares JM, Jimenez ML, Lopez-Brea M.
Scand J Gastroenterol Suppl. 1988;142:107-9.
[Properties of a new drug famocid: indications and contraindications of its use?].
Okhlobystin AV.
Klin Med (Mosk). 1995;73(2):68. Russian. No abstract available.
Eradication of Helicobacter pylori by a combination of amoxicillin and famotidine.
Gschwantler M, Weiss W, Penka G, Zirm B, Stupnicki T, Spath P.
Am J Gastroenterol. 1995 Sep;90(9):1542. No abstract available.
[Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
Dallera F, Scanzi G, Gendarini A.
Clin Ter. 1994 Jan;144(1):23-6. Italian.
Famotidine for gastric radiography.
Tanioka H, Araki T, Sasaki Y, Yoshikawa K.
Radiat Med. 1993 Jan-Feb;11(1):12-6.
Comparison of roxatidine and famotidine on nocturnal gastric juice secretion.
Tanioka H, Kaga K.
J Int Med Res. 1996 Jan-Feb;24(1):88-91.
Reversion by histamine H2-receptor antagonists of plasma membrane alterations in ethanol-induced gastritis.
Hernández-Muñoz R, Montiel-Ruíz F.
Dig Dis Sci. 1996 Nov;41(11):2156-65.
[Effect of a novel antiulcer drug, lafutidine, on experimental chronic gastritis in rats].
Onodera S, Tanaka M, Inaba N, Suzuki T, Shibata M, Yamaura T.
Nihon Yakurigaku Zasshi. 1997 Jan;109(1):31-40. Japanese.
[Bicarbonate deficiency and duodenal peptic ulcer].
Malov IuS, Kulikov AN.
Ter Arkh. 1998;70(2):28-32. Russian.
[A case of the phlegmonous gastritis successfully treated by conservative therapy].
Kato K, Sasaki H, Ido M, Iwata M, Naganuma T, Fujimori K.
Nihon Shokakibyo Gakkai Zasshi. 1998 May;95(5):432-5. Japanese. No abstract available.
Use of a [13C]urea breath test for detection of gastric infection with Helicobacter spp in dogs.
Cornetta AM, Simpson KW, Strauss-Ayali D, McDonough PL, Gleed RD.
Am J Vet Res. 1998 Nov;59(11):1364-9.
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Rollan A, Giancaspero R, Fuster F, Acevedo C, Figueroa C, Hola K, Schulz M, Duarte I.
Am J Gastroenterol. 2000 Jan;95(1):50-6.
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Mashiba H, Sasaki N, Taniyama K.
Aliment Pharmacol Ther. 2000 Oct;14(10):1345-52.
[Intravenous treatment with quamatel in reflux-esophagus and erosive gastritis].
Ivanova S, Gavrilova V, Dimitrov L.
Vutr Boles. 2000;32(4):48-51. Bulgarian.
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Mak SK, Loo CK, Wong AM, Wong PN, Lo KY, Tong GM, Lam EK, Wong AK.
Am J Kidney Dis. 2002 Sep;40(3):576-81.
Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
Hu FL, Jia JC, Li YL, Yang GB.
J Int Med Res. 2003 Nov-Dec;31(6):469-74.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on